Stat Med. 1997 Feb 28;16(4):425-40.

Estimating the completeness of prevalence based on cancer registry data.

Source

Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanitá, Roma, Italy.

Abstract

Prevalence data provided by cancer registries are generally biased, since the patients that were diagnosed before the starting of the registry's activity cannot be included in the statistics. The relevance of this incompleteness bias is estimated in this paper. Incidence and relative survival are modelled as parametric functions describing a wide class of cancer diseases. Prevalence estimates are then computed considering different hypotheses on disease reversibility. The ratio between the prevalence observed by the registry and the total estimated prevalence is used as an index of completeness. An analytical evaluation of this ratio, as a function of the parameters characterizing the observational process and the biological behaviour of the disease, is given.

PMID:: 9044530; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

LinkOut - more resources

Full Text Sources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. [Int J Epidemiol. 2000]
Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program.
Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Int J Epidemiol. 2000 Apr; 29(2):197-207.
Correcting the completeness bias of observed prevalence. [Tumori. 1999]
Correcting the completeness bias of observed prevalence.
Corazziari I, Mariotto A, Capocaccia R. Tumori. 1999 Sep-Oct; 85(5):370-81.
Cancer prevalence in Italian regions with local cancer registries. [Tumori. 1999]
Cancer prevalence in Italian regions with local cancer registries.
Mariotto A, Dally LG, Micheli A, Canario F, Verdecchia A. Tumori. 1999 Sep-Oct; 85(5):400-7.
Review Measuring cancer prevalence in Europe: the EUROPREVAL project. [Ann Oncol. 2002]
Review Measuring cancer prevalence in Europe: the EUROPREVAL project.
Capocaccia R, Colonna M, Corazziari I, De Angelis R, Francisci S, Micheli A, Mugno E, EUROPREVAL Working Group. Ann Oncol. 2002 Jun; 13(6):831-9.
Review Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. [Eur J Cancer. 2009]
Review Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.
Parkin DM, Bray F. Eur J Cancer. 2009 Mar; 45(5):756-64. Epub 2009 Jan 6.

See reviews... See all...

Cited by 8 PubMed Central articles

Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry. [BMC Public Health. 2012]
Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry.
Pavlík T, Májek O, Mužík J, Koptíková J, Slavíček L, Fínek J, Feltl D, Vyzula R, Dušek L. BMC Public Health. 2012 Feb 10; 12:117. Epub 2012 Feb 10.
Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty. [BMC Public Health. 2011]
Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty.
van Baal PH, Engelfriet PM, Hoogenveen RT, Poos MJ, van den Dungen C, Boshuizen HC. BMC Public Health. 2011 Mar 15; 11:163. Epub 2011 Mar 15.
Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors. [Cancer Causes Control. 2011]
Getting cancer prevalence right: using state cancer registry data to estimate cancer survivors.
Carpenter WR, Yeh WS, Wobker SE, Godley PA. Cancer Causes Control. 2011 May; 22(5):765-73. Epub 2011 Mar 1.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Estimating the completeness of prevalence based on cancer registry data.
Estimating the completeness of prevalence based on cancer registry data.
Stat Med. 1997 Feb 28 ;16(4):425-40.

PubMed
Stationary-phase regulation of the Saccharomyces cerevisiae SOD2 gene is depende...
Stationary-phase regulation of the Saccharomyces cerevisiae SOD2 gene is dependent on additive effects of HAP2/3/4/5- and STRE-binding elements.
Mol Microbiol. 1997 Jan ;23(2):303-12.

PubMed
Problems of diagnosis in the evaluation of mediastinal sarcoidosis.
Problems of diagnosis in the evaluation of mediastinal sarcoidosis.
Laryngoscope. 1977 Oct ;87(10 Pt 1):1635-44.

PubMed
Waist circumference reduction and cardiovascular benefits during weight loss in ...
Waist circumference reduction and cardiovascular benefits during weight loss in women.
Int J Obes Relat Metab Disord. 1997 Feb ;21(2):127-34.

PubMed
Preterm delivery and growth restriction in multifetal pregnancies reduced to twi...
Preterm delivery and growth restriction in multifetal pregnancies reduced to twins.
Hum Reprod. 1997 Jan ;12(1):173-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: